Bolivia Chikungunya Outbreak: 5 Deaths, Cases Surging in Santa Cruz

Chikungunya Fever Outbreak in Bolivia Intensifies, Reaching Five Confirmed Deaths

La Paz, Bolivia – A rapidly escalating outbreak of chikungunya fever in Bolivia has claimed the lives of five people, with health officials reporting a surge in cases, particularly in the eastern department of Santa Cruz. The outbreak, fueled by the East/Central/South African (ECSA) genotype of the virus, is prompting increased public health measures and raising concerns about the potential for further spread across the country. As of February 26, 2026, Bolivia has recorded 5,518 total chikungunya cases, including 3,976 confirmed infections, according to data from the Pan American Health Organization (PAHO).

The situation is particularly acute in Santa Cruz, where nearly 1,000 new cases were reported in the last epidemiological week alone. Julio Cesar Koca, Director of the Departmental Health Service (SEDES), stated that the epidemiological curve has not yet peaked, indicating the outbreak is still expanding. Health authorities are bracing for a potential peak in cases within the next three weeks, contingent on a cessation of the rains that contribute to mosquito breeding grounds. A red alert for the epidemic was activated on February 9th following the first confirmed fatality.

A New Genotype Drives the Outbreak

The current outbreak is being driven by the ECSA genotype of the chikungunya virus, a strain that has been circulating in Bolivia since 2025 and continues to be a significant factor in early 2026. This emergence of a new genotype is adding complexity to the public health response, as it may present different clinical characteristics or require adjustments to existing control strategies. Christian Quiroga, head of Epidemiology at the Municipal Health Secretariat in Santa Cruz de la Sierra, noted a concerning new symptom associated with the ECSA genotype: meningitis, or inflammation of the tissues surrounding the brain and spinal cord. This development necessitates urgent medical attention, as it can be life-threatening, especially for individuals with underlying health conditions.

Chikungunya fever is a viral disease transmitted to humans through the bite of infected Aedes aegypti and Aedes albopictus mosquitoes. Symptoms typically include high fever, severe joint and muscle pain, headache and fatigue. While fatalities are rare, the disease can cause debilitating joint pain that persists for weeks, months, or even years. The U.S. Centers for Disease Control and Prevention (CDC) issued a Level 2 – Practice Enhanced Precautions Travel Health Notice for chikungunya in Bolivia on February 11, 2026, specifically highlighting outbreaks in Santa Cruz and Cochabamba departments. More information on travel health notices can be found on the CDC website.

Regional Spread and Public Health Response

While Santa Cruz remains the epicenter of the outbreak, cases have been reported in seven of Bolivia’s nine departments, including Cochabamba, Tarija, Beni, Chuquisaca, and Pando. This broader geographic spread underscores the urgency of a coordinated national response. In 2025, Bolivia reported 4,696 confirmed chikungunya cases and four deaths throughout the entire year, demonstrating a significant increase in cases in the early weeks of 2026.

Health brigades have been deployed to affected areas to intensify fumigation efforts and eliminate mosquito breeding grounds in both urban neighborhoods and the surrounding periphery of 27 municipalities in the Santa Cruz department. These efforts are crucial in controlling the mosquito population and reducing the risk of further transmission. Carlos Hurtado, head of Epidemiology at Sedes, emphasized the importance of community involvement, stating, “We are still seeing an increase in positive cases…what remains for us as health authorities and as a population is to work in our homes, insisting on the elimination of mosquito breeding grounds.”

Impact on Tourism and Travel

The surge in chikungunya cases is as well raising concerns about the potential impact on Bolivia’s tourism sector. The country is expecting over 1 million visitors in 2026, and the outbreak could deter some travelers. However, the PAHO currently advises no travel restrictions for Bolivia. The CDC’s travel health notice recommends practicing enhanced precautions, primarily focusing on mosquito bite prevention. Vax-Before-Travel News reports that the outbreak highlights vaccination options for travelers.

Preventing Chikungunya: Protecting Yourself

Preventing chikungunya infection relies heavily on avoiding mosquito bites. Public health officials recommend the following measures:

• Utilize insect repellent: Apply repellent containing DEET, picaridin, or IR3535 to exposed skin and clothing.
• Wear protective clothing: Cover up with long sleeves, long pants, and socks when outdoors, especially during peak mosquito activity hours.
• Eliminate mosquito breeding grounds: Remove standing water from containers such as flower pots, tires, and buckets.
• Use mosquito nets: Sleep under mosquito nets, especially if you are not in an air-conditioned room.
• Stay in accommodations with air conditioning or screens: This helps to keep mosquitoes out.

Currently, there is no specific antiviral treatment for chikungunya fever. Treatment focuses on relieving symptoms, such as fever and joint pain. Rest, hydration, and pain relievers are typically recommended. There is a chikungunya vaccine available, and vaccination is recommended for people traveling to areas with a chikungunya outbreak.

Key Takeaways

• Bolivia is experiencing a significant chikungunya outbreak, with 5,518 cases reported in the first seven weeks of 2026.
• The outbreak is driven by the ECSA genotype of the virus, which is associated with a new symptom – meningitis.
• Santa Cruz is the epicenter of the outbreak, but cases have been reported in seven of Bolivia’s nine departments.
• Prevention relies on avoiding mosquito bites through the use of repellent, protective clothing, and eliminating breeding grounds.
• The PAHO does not recommend travel restrictions, but the CDC advises practicing enhanced precautions.

Health officials will continue to monitor the situation closely and provide updates as the outbreak evolves. The next official update from the PAHO regarding the chikungunya outbreak in Bolivia is expected on March 5, 2026. Readers are encouraged to share this information and to consult with healthcare professionals for personalized advice on preventing and managing chikungunya fever.